26/10/2022 - 13:13

Radiopharm secures vital cancer-fighting ingredient

26/10/2022 - 13:13

Bookmark

Save articles for future reference.

ASX-listed medical technology specialist Radiopharm Theranostics has strengthened the supply chain for a critical ingredient in its cancer-fighting treatments by inking a 10-year deal with an American supplier. The agreement with Wisconsin-based NorthStar Medical Radioisotopes is for Actinium-225, also known as Ac-225, which is a radioactive medical isotope used in a wide range of cancer treatments.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options